Evaluation of the Veriton SPECT/CT System

Purpose

The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.

Condition

  • Focus of Study is Comparison of 2 Types of Gamma Cameras

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults age 18 years or older. - Currently scheduled to undergo a nuclear medicine exam.

Exclusion Criteria

  • Individuals under 18 years of age. - Unwilling/unable to sign an informed consent form. - Unable to lie on a Veriton imaging table for up to 40 minutes.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
each patient will have 2 scans - one on a conventional system and one on the newer technology
Primary Purpose
Diagnostic
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Evaluation of the Veriton SPECT/CT system
To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.
  • Diagnostic Test: Veriton SPECT/CT
    The Veriton system represents an FDA approved (510k cleared) new generation of SPECT/CT systems. It consists of 12 small gamma cameras arrayed in a circle around the patient, and is coupled to a 64-slice CT system.

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905

More Details

NCT ID
NCT04722185
Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Kera Delaney
507-293-5660
Delaney.Kera@mayo.edu